XML 17 R8.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities attributable to continuing operations:      
Net (loss) earnings $ (533,330) $ 258,317 $ (1,192,455)
Less: Earnings (loss) from discontinued operations, net of tax 39,838 (36,550) (116,046)
Net (loss) earnings from continuing operations (573,168) 294,867 (1,076,409)
Adjustments to reconcile net (loss) earnings attributable to continuing operations to net cash provided by (used in) operating activities attributable to continuing operations:      
Unrealized loss (gain) on investment in MGM Resorts International (649,178) 721,668 (723,515)
Amortization of intangibles 141,906 288,012 293,277
Stock-based compensation expense 77,745 73,562 70,808
Depreciation 40,838 80,937 52,716
Non-cash lease expense (including right-of-use asset impairments) 38,663 90,539 56,915
Provision for credit losses 4,688 5,699 8,402
Deferred income taxes (156,659) 88,403 (313,575)
Unrealized (increase) decrease in the estimated fair value of a warrant (20,393) (2,832) 62,495
(Gains) losses on sales of businesses and investments in equity securities (including downward and upward adjustments), net (10,493) 18,133 (38,956)
Pension and post-retirement benefit (credit) cost (5,453) 76 209,991
Goodwill impairment 0 9,000 86,748
Other adjustments, net (1,086) (11,051) 14,651
Changes in assets and liabilities, net of effects of dispositions:      
Accounts receivable (6,398) 12,140 49,810
Other assets 74,929 23,393 9,213
Operating lease liabilities (51,031) (53,623) (47,738)
Accounts payable and other liabilities (8,732) (106,557) (259,556)
Income taxes payable and receivable 2,738 (2,677) (9,942)
Deferred revenue (4,809) (9,032) (8,217)
Net cash provided by (used in) operating activities attributable to continuing operations 192,463 77,321 (115,852)
Cash flows from investing activities attributable to continuing operations:      
Capital expenditures (15,014) (93,584) (23,401)
Net proceeds from sales of fixed assets 12,751 29,394 9,514
Proceeds from maturities of marketable debt securities 375,000 537,500 0
Purchases of marketable debt securities (221,788) (443,051) (233,928)
Net proceeds from the sales of businesses and investments 177,163 10,861 90,767
Purchase of retirement investment fund (15,968) 0 0
Proceeds from the sale of retirement investment fund 2,326 0 0
Net collections of notes receivable 11,834 11,297 19,497
Purchases of investments (53) (103,555) (3,036)
Purchases of investment in MGM Resorts International 0 0 (244,256)
Other, net 985 9,902 6,121
Net cash provided by (used in) investing activities attributable to continuing operations 327,236 (41,236) (378,722)
Cash flows from financing activities attributable to continuing operations:      
Principal payments on Dotdash Meredith Term Loans (67,964) (30,000) (30,000)
Proceeds from the issuance of Dotdash Meredith Term Loan B-1 7,964 0 0
Proceeds from the exercise of stock options 0 130 0
Withholding taxes paid on behalf of employees on net settled stock-based awards (14,976) (10,587) (18,068)
Purchases of treasury stock 0 (165,622) (85,323)
Purchase of noncontrolling interests 0 0 (1,179)
Proceeds from the issuance of Vivian Health preferred shares, net of fees 0 0 34,700
Other, net (1,912) 49 4,446
Net cash used in financing activities attributable to continuing operations (76,888) (206,030) (95,424)
Total cash provided by (used in) continuing operations 442,811 (169,945) (589,998)
Net cash provided by operating activities attributable to discontinued operations 162,055 112,207 33,061
Net cash used in investing activities attributable to discontinued operations (50,411) (46,231) (116,086)
Net cash used in financing activities attributable to discontinued operations (52,211) (16,983) (17,227)
Total cash provided by (used in) discontinued operations 59,433 48,993 (100,252)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (1,230) 1,124 (5,545)
Net increase (decrease) in cash and cash equivalents and restricted cash 501,014 (119,828) (695,795)
Cash and cash equivalents and restricted cash at beginning of period 1,306,241 1,426,069 2,121,864
Cash and cash equivalents and restricted cash at end of period $ 1,807,255 $ 1,306,241 $ 1,426,069